Childhood sarcoidosis: Louisiana experience

Abstract

A retrospective chart review was conducted to detect patients with sarcoidosis seen by pediatric rheumatology service from the period of 1992 to 2013 at Children’s hospital of New Orleans. Twenty-seven patients were identified. The average duration of symptoms before diagnosis was 5 (range 1–120) months. Five patients had onset before the age of 5 years and were diagnosed with early-onset sarcoidosis. The most common manifestations at presentation were constitutional symptoms (62 %) followed by ocular (38 %). During the course of illness, 19/27 (70 %) had multiorgan involvement. Common manifestations included uveitis/iritis (77 %), fever (50 %), hilar adenopathy (42 %), arthritis (31 %), peripheral lympadenopathy (31 %), hepatosplenomegaly (31 %), parenchymal lung disease (27 %), and skin rash (19 %). Unusual manifestations included granulomatous bone marrow disease (3 cases), hypertension (2), abdominal aortic aneurysm (large vessel vasculitis; 1), granulomatous hepatitis (1), nephrocalcinosis (1), membranous nephropathy (1), refractory granulomatous interstitial nephritis with recurrence in transplanted kidney (1), CNS involvement (2), parotid gland enlargement (1), and sensorineural hearing loss (1). Biopsy specimen was obtained in 21/27 (77 %) patients, and demonstration of noncaseating granuloma associated with negative stains for mycobacteria and fungi was seen in 18 patients. Elevated angiotensin-converting enzyme level was seen in 74 % of patients. Treatment with oral prednisone was initiated in symptomatic patients with significant clinical improvement. Low-dose methotrexate (MTX) 10–15 mg/m2/week orally, as steroid-sparing agent, was administered in 14 patients. Other immunomodulators included cyclophosphamide (2 patients), etanercept (2), infliximab (2), mycophenolate mofetil (1), and tacrolimus (1). Childhood sarcoidosis is prevalent in Louisiana. Most of the affected children present with a multisystem disease associated with manifestations similar to those of adult patients. Low-dose MTX seems to be effective, steroid sparing, and safe adjunct to treat sarcoidosis with multiorgan involvement. Early-onset disease is less common and associated with increased morbidity, flares, and poor prognosis.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement of sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173

    CAS  PubMed  Google Scholar 

  2. 2.

    Hoffman AL, Milman N, Byg KE (2004) Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr 93:30–36

    Article  Google Scholar 

  3. 3.

    Shetty AK, Gedalia A (2008) Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online J 6:16

    Article  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarcoidosis. J Pediatr 108:169–177

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Kendig EL Jr (1989) Sarcoidosis in children. Personal observations on age distribution. Pediatric Pulmonol 6:69–70

    Article  Google Scholar 

  6. 6.

    Touitou I, Kone-Paut I (2008) Autoinflammatory diseases. Best Pract Res Clin Rheumatol 22:811–829

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarcoidosis. J Pediatr 108:169–177

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Laghmari M, Skiker H, Boutimzine N, Daoudi R (2008) Uveitis during the course of sarcoidosis in a child: difficult diagnosis of a case. Bull Soc Belge Ophtalmol 307:47–51

    PubMed  Google Scholar 

  9. 9.

    Gedalia A, Shetty AK, Ward KJ, Correa H, Heinrich S (1997) Role of MRI in diagnosis of childhood sarcoidosis with fever of unknown origin. J Pediatr Orthop 17:460–462

    CAS  PubMed  Google Scholar 

  10. 10.

    Pattishall EN, Kendig EL Jr (1996) Sarcoidosis in children. Pediatr Pulmonol 22:195–203

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Nocton JJ, Stork JE, Jacobs G, Newman AJ (1992) Sarcoidosis associated with nephrocalcinosis in young children. J Pediatr 121:937–940

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Hafner R, Vogel P (1993) Sarcoidosis of early onset. A challenge for the pediatric rheumatologist. Clin Exp Rheumatol 11:685–691

    CAS  PubMed  Google Scholar 

  13. 13.

    Gedalia A, Shetty AK, Ward K, Correa H, Venters CL, Loe WA (1996) Abdominal aortic aneurysm associated with childhood sarcoidosis. J Rheumatol 23:757–759

    CAS  PubMed  Google Scholar 

  14. 14.

    Baumann RJ, Robertson WC (2003) Neurosarcoid presents differently in children than in adults. Pediatrics 112:e480–486

    Article  PubMed  Google Scholar 

  15. 15.

    Shetty AK, Gedalia A (2000) Sarcoidosis in children. Curr Probl Pediatr 30:149–176

    CAS  PubMed  Google Scholar 

  16. 16.

    Rodriguez GE, Shin BC, Abernathy RS (1981) Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. J Pediatr 99:68–72

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J (1990) Serum angiotensin-converting enzyme activity in normal children and in those with sarcoidosis. Clin Chem 36:344–346

    CAS  PubMed  Google Scholar 

  18. 18.

    Marcille R, McCarthy M, Barton JW, Merten DF, Spock A (1992) Long-term outcome of pediatric sarcoidosis with emphasis on pulmonary status. Chest 102:1444–1449

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Milman N, Hoffmann AL (2008) Childhood sarcoidosis: longterm follow-up. Eur Respir J 31:592–598

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Milman N, Svendsen CB, Hoffmann AL (2009) Health-related quality of life in adult survivors of childhood sarcoidosis. Respir Med 103:913–918

    Article  PubMed  Google Scholar 

  21. 21.

    Gedalia A, Molina JF, Ellis GS Jr, Galen W, Moore C, Espinoza LR (1997) Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr 130:25–29

    CAS  Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Abraham Gedalia.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gedalia, A., Khan, T.A., Shetty, A.K. et al. Childhood sarcoidosis: Louisiana experience. Clin Rheumatol 35, 1879–1884 (2016). https://doi.org/10.1007/s10067-015-2870-9

Download citation

Keywords

  • Early-onset childhood sarcoidosis
  • Methotrexate
  • Prednisone
  • Steroid sparing